Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lexeo Therapeutics Inc. C...

    NASDAQ: LXEO · Real-Time Price · USD
    3.90
    -0.02 (-0.51%)
    At close: Jun 17, 2025, 3:59 PM
    4.11
    5.25%
    After-hours: Jun 17, 2025, 05:08 PM EDT

    Lexeo Therapeutics Common Stock Statistics

    Share Statistics

    Lexeo Therapeutics Common Stock has 33.2M shares outstanding. The number of shares has increased by 0.76% in one year.

    Shares Outstanding

    n/a
    		 33.2M

    Shares Change (YoY)

    n/a
    		 0.76%

    Shares Change (QoQ)

    n/a
    		 0.4%

    Owned by Institutions (%)

    n/a
    		 87.86%

    Shares Floating

    n/a
    		 25.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 94,224

    FTD / Avg. Volume

    n/a
    		 9.24%

    Short Selling Information

    The latest short interest is 3.78M, so 11.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.78M

    Short % of Shares Out

    n/a
    		 11.39%

    Short % of Float

    n/a
    		 13.28%

    Short Ratio (days to cover)

    n/a
    		 4.65

    Valuation Ratios

    The PE ratio is -2.13 and the forward PE ratio is -1.95. Lexeo Therapeutics Common Stock's PEG ratio is -0.09.

    PE Ratio

    n/a
    		 -2.13

    Forward PE

    n/a
    		 -1.95

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 1.79

    P/FCF Ratio

    n/a
    		 -2.56

    PEG Ratio

    n/a
    		 -0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lexeo Therapeutics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 5.52

    Quick Ratio

    n/a
    		 5.52

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -927.77

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,311,106.67

    Employee Count

    n/a
    		 75

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -75.69% in the last 52 weeks. The beta is 0.52, so Lexeo Therapeutics Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -75.69%

    50-Day Moving Average

    n/a
    		 3.17

    200-Day Moving Average

    n/a
    		 5.86

    Relative Strength Index (RSI)

    n/a
    		 57.15

    Average Volume (20 Days)

    n/a
    		 1,019,387

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -105.77M

    Net Income

    n/a
    		 -98.33M

    EBITDA

    n/a
    		 -96.22M

    EBIT

    n/a
    		 -98.47M

    Earnings Per Share (EPS)

    n/a
    		 -3.09
    Full Income Statement

    Balance Sheet

    The company has 35.01M in cash and 9.92M in debt, giving a net cash position of 25.09M.

    Cash & Cash Equivalents

    n/a
    		 35.01M

    Total Debt

    n/a
    		 9.92M

    Net Cash

    n/a
    		 25.09M

    Retained Earnings

    n/a
    		 -280.17M

    Total Assets

    n/a
    		 125.69M

    Working Capital

    n/a
    		 74.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -81.15M and capital expenditures -481K, giving a free cash flow of -81.63M.

    Operating Cash Flow

    n/a
    		 -81.15M

    Capital Expenditures

    n/a
    		 -481K

    Free Cash Flow

    n/a
    		 -81.63M

    FCF Per Share

    n/a
    		 -2.57
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LXEO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LXEO is $18, which is 355.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $18

    Price Target Difference

    n/a
    		 355.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.22

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist